These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33358563)

  • 1. The epidemiology, genotypes, antifungal susceptibility of Trichosporon species, and the impact of voriconazole on Trichosporon fungemia patients.
    Kuo SH; Lu PL; Chen YC; Ho MW; Lee CH; Chou CH; Lin SY
    J Formos Med Assoc; 2021 Sep; 120(9):1686-1694. PubMed ID: 33358563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive Infections Due to
    Guo LN; Yu SY; Hsueh PR; Al-Hatmi AMS; Meis JF; Hagen F; Xiao M; Wang H; Barresi C; Zhou ML; de Hoog GS; Xu YC
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing.
    Chagas-Neto TC; Chaves GM; Melo AS; Colombo AL
    J Clin Microbiol; 2009 Apr; 47(4):1074-81. PubMed ID: 19225102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen.
    Dabas Y; Xess I; Kale P
    Med Mycol; 2017 Jul; 55(5):518-527. PubMed ID: 27816903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
    Francisco EC; de Almeida Junior JN; de Queiroz Telles F; Aquino VR; Mendes AVA; de Andrade Barberino MGM; de Tarso O Castro P; Guimarães T; Hahn RC; Padovan ACB; Chaves GM; Colombo AL
    Clin Microbiol Infect; 2019 Jul; 25(7):909.e1-909.e5. PubMed ID: 30991116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular identification, genotyping, and antifungal susceptibility testing of clinically relevant Trichosporon species from Argentina.
    Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G; Bosco-Borgeat ME
    Med Mycol; 2014 May; 52(4):356-66. PubMed ID: 24682113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of
    Francisco EC; de Almeida Junior JN; Queiroz-Telles F; Aquino VR; Mendes AVA; de Oliveira Silva M; Castro PTOE; Guimarães T; Ponzio V; Hahn RC; Chaves GM; Colombo AL
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318016
    [No Abstract]   [Full Text] [Related]  

  • 8. Intergenic spacer (IGS-1) region sequence-based identification, genotypic analysis, and antifungal susceptibility of clinical Trichosporon species.
    Parashar A; Rastogi V; Prakash H; Pandey A; Rudramurthy SM
    Indian J Med Microbiol; 2023; 45():100390. PubMed ID: 37573054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples.
    Ahangarkani F; Ilkit M; Vaseghi N; Zahedi N; Zomorodian K; Khodavaisy S; Afsarian MH; Abbasi K; de Groot T; Meis JF; Badali H
    Mycoses; 2021 Aug; 64(8):918-925. PubMed ID: 33998718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
    Kimura M; Araoka H; Yamamoto H; Nakamura S; Nagi M; Yamagoe S; Miyazaki Y; Ogura S; Mitsuki T; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Shimazu H; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Wake A; Taniguchi S; Yoneyama A
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
    Ruan SY; Chien JY; Hsueh PR
    Clin Infect Dis; 2009 Jul; 49(1):e11-7. PubMed ID: 19489711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
    Rastogi V; Honnavar P; Rudramurthy SM; Pamidi U; Ghosh A; Chakrabarti A
    Mycoses; 2016 Aug; 59(8):528-34. PubMed ID: 27144725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and Antifungal Susceptibility of Infections Caused by
    Singh S; Capoor MR; Varshney S; Gupta DK; Verma PK; Ramesh V
    Indian J Med Microbiol; 2019; 37(4):536-541. PubMed ID: 32436877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence-based identification, genotyping and EUCAST antifungal susceptibilities of Trichosporon clinical isolates from Greece.
    Arabatzis M; Abel P; Kanellopoulou M; Adamou D; Alexandrou-Athanasoulis H; Stathi A; Platsouka E; Milioni A; Pangalis A; Velegraki A
    Clin Microbiol Infect; 2014 Aug; 20(8):777-83. PubMed ID: 24330082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
    Sun W; Su J; Xu S; Yan D
    J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype analysis based on intergenic spacer 1 sequences of Trichosporon asahii collected in Taiwan.
    Yang YL; Liu YW; Chen HT; Tsai MS; Chu WL; Lo HJ
    Med Mycol; 2013 Nov; 51(8):880-3. PubMed ID: 23768241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
    Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
    Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients.
    Xia Z; Yang R; Wang W; Cong L
    Mycopathologia; 2012 Mar; 173(2-3):127-33. PubMed ID: 21979867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
    Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
    Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
    Itoh K; Iwasaki H; Negoro E; Shigemi H; Tokimatsu I; Tsutani H; Yamauchi T
    Mycopathologia; 2021 Mar; 186(1):113-117. PubMed ID: 33389484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.